Genetic analysis of a heterozygous protein C-deficient patient revealed a novel deletion of a single guanine residue ("'7G) among four consecutive guanine nucleotides [3Trp(TGG)-31Gly(GGT)j in exon IX, which encodes the carboxyl-terminal region of protein C. This deletion results in a frameshift mutation and substitution of the last 39 amino acids ("1Gly-419Pro) with 81 abnormal amino acid residues, and we have designated this elongated variant as Protein C-Nagoya. A mutagenic primer was designed which replaced the third guanine residue upstream from the deletion with cytosine, thereby creating a new Aval site in an otherwise normal allele. Analysis of the polymerase chain reaction products derived from this. mutagenic primer showed that the abnormal allele has been inherited in this family. To elucidate how this molecular abnormality leads to protein C deficiency, an expression plasmid containing this mutation was transfected into COS 7, BHK, and P-2 cells, and the secretory process of the expressed Protein C-Nagoya was analyzed. ELISA and immunoprecipitation analysis with I35Slmethionine labeling indicated that the mutant protein C, which was larger in size than normal, was mostly retained within the cells, and only a small portion of it was secreted into the medium. These results suggest that most of Protein C-Nagoya undergoes degradation within the producing cells, and this frameshift mutation apparently leads to protein C deficiency by impairment of secretion of the elongated protein C into plasma. (J. Clin. Invest. 1992.90:2439-2446
Introduction
Protein C is a vitamin K-dependent plasma glycoprotein with an estimated molecular mass of 62 kD, consisting of a heavy chain of 41 kD and a light chain of 21 kD linked by disulfide bridges ( 1, 2) . It is a precursor of a plasma seine protease, activated protein C, which acts as an anticoagulant by inactivating Factors Va and VIlla (3, 4) , and stimulates fibrinolysis by reducing the activity of tissue-type plasminogen activator inhibitor (5) . In some families, a compelling relationship be-tween thromboembolic disease and heterozygosity for protein C deficiency has been found (6, 7) , but the vast majority of heterozygotes are asymptomatic (8) . The prevalence of a heterozygous protein C deficiency associated with a predisposition towards thrombosis has been estimated in about 1 out of 16,000 individuals (9) . Homozygous protein C-deficient patients, who have little or no detectable plasma levels of protein C, suffer from very severe thromboembolic disease and purpura fulminans from the perinatal period onwards ( 10). Hereditary protein C deficiency has been classified into two major groups: type I deficiency, which has equivalent reductions in enzymatic activity and in antigenic concentration, and type II deficiency, wherein only protein C activity is reduced ( 11) .
A full-length cDNA and a genomic copy of protein C have been cloned and sequenced (12) (13) (14) (15) , and the gene has been mapped to chromosome 2 (16) . Several abnormalities in the DNA have been found to underlie protein C deficiency; these include gross deletions, nonsense mutations, missense mutations, and a frameshift mutation (17) (18) (19) (20) (21) (22) . In the present study, we studied the molecular basis of a type I protein C-deficient heterozygote and characterized a single nucleotide deletion, which causes a frameshift mutation. To elucidate the mechanism by which the frameshift mutation causes reductions of protein C levels in plasma, transient and stable expression experiments were performed using COS 7, BHK, and 4-2 cells. Functional aspects of recombinant protein C molecules have been previously analyzed using in vitro mutagenesis techniques (23-25). However, expression study of the abnormal protein C, which is supposed to be responsible for the protein C-deficient state clinically, has not yet been performed. Only a small amount ofthe recombinant mutant protein C designated as Protein C-Nagoya with an apparent elongated molecular mass was secreted into the cell culture media, suggesting that this mutation may be the molecular basis for protein C deficiency in this pedigree.
Methods
Patient profile. The patient is a 46-yr-old man who has had recurrent episodes ofthrombosis. His first episode was right leg deep vein thrombosis diagnosed by venography at the age of 42. 3 mo later, he was admitted to a hospital because of chest pain and dyspnea. Pulmonary embolism was confirmed by lung perfusion scintigraphy using [99m-Tc] macroaggregated albumin. I wk after admission, a low density area was noted in the lateral lobe of the left cerebral hemisphere in a computer tomography scan of the brain, which was probably related to vascular occlusion. Since then, the patient has taken warfarin (3-5 mg daily) and has had no other thromboembolic episodes.
DNA samples. Blood samples were taken from the patient and his family members with informed consent. Nine parts blood were mixed with one part 3.8% trisodium citrate, and the plasma was then separated by centrifugation at 3,400 g for 15 min at 4VC and stored at -80°C until use. Genomic DNA was isolated from peripheral blood leukocytes by phenol extraction, as previously described (26). Protein C assays. Protein C activity was determined using protein C-deficient plasma as a substrate and Protac® (Boehringer Mannheim GmbH, Mannheim, Germany) as an activator of protein C (Staclot Protein CO; Boehringer Mannheim) (27) .
Two different ELISAs were used to determine protein C antigen levels. Total protein C antigen level was first measured using a polyclonal rabbit serum against human protein C (Asserachrom Protein CO; Boehringer Mannheim). The level ofcalcium-dependent protein C antigen was also measured using a rabbit monoclonal antibody that recognizes a conformational change in the gamma carboxyglutamic acid ofa glutamate residue (Gla) (TD-82; Teijin, Tokyo, Japan).
Protein C activity and antigen levels in the samples were expressed as percentages of those observed in pooled plasma from 20 normal individuals (28) . The levels of protein C activity and antigen in the pooled plasma were both defined as 100%.
Western blot analysis. 200 Mil ofthe test plasma was diluted with 800 td of 0.32% sodium citrate in 50 mM Tris-HCl, pH 7.5. Barium citrate adsorption was then carried out by adding 40 td of 1 M BaCl2 to the diluted plasma and chilling it on ice for 60 min. After 5 min ofcentrifugation at 10,000 g, the supernatant was discarded, and the pellet was redissolved in 100 ,d of 0.25 M EDTA, 50 ,M Tris-HCl, pH 7.5 (29) .
The samples were dialyzed against distilled water, dried, and subjected to SDS-PAGE, and the fractionated proteins were electrically transferred to nitrocellulose paper for immunological detection.
Plasma protein C was then immunolabeled with a rabbit anti-protein C polyclonal antibody provided by Dr pmol of each primer, and 2.5 U of recombinant Taq DNA polymerase (Perkin Elmer-Cetus, Norwalk, CT). The mixture was overlaid with mineral oil to avoid condensation and subjected to 35 cycles ofamplification. The samples were denatured at 94°C for 1 min, annealed at 60°C for 2 min, and subsequently heated to polymerize at 72°C for 2 min in an automatic thermal cycler (Perkin Elmer-Cetus). DNA sequencing. The PCR products were digested with EcoRI endonuclease, then subcloned into Mi 3 vectors to obtain single-strand DNA fragments. These fragments were sequenced by the dideoxy chain termination method as described previously (28, 31) . The possibility of mispolymerization by Taq polymerase was ruled out by sequencing multiple clones with distinct orientation.
Construction of expression vectors. An expression vector for the normal protein C (pEUK-PC) was constructed as follows by inserting a cDNA fragment coding for protein C into pEUK-C (Clonetech, Palo Alto, CA). The cDNA fragment encoding normal protein C, provided by Dr. Earl W. Davie (University of Washington, Seattle, WA) in pUC 19, contained two EcoRI sites, between which lay 69 noncoding bases 5' of the ATG initiation site, 126 bases of leader sequence, 1,383 bases encoding the entire protein C molecule, and 202 noncoding bases 3' of the TAG stop codon; the latter region including two poly(A) signals. This fragment was excised from pUC19 by EcoRI digestion and ligated into the multicloning site ofthe pBluescript KS II(+). The direction of insertion was confirmed by digestion with NaeI. For insertion into the mammalian cell expression vector (pEUK-C), which has the SV40 late promoter upstream of the XbaI site, the cDNA was excised from pBluescript KS II(+) by XbaI-XhoI digestion and inserted into these same restriction sites in pEUK-C.
Similarly, the retroviral vector (pLXSN-PC) was constructed by inserting a normal protein C cDNA fragment into EcoRI restriction Mutagenesis. Site-directed mutagenesis ofthe protein C coding sequences was performed for a single G deletion at nucleotide 8857 using an oligonucleotide-directed in vitro Mutagenesis System@, version 2.0 (Amersham Corp., Arlington Heights, IL) (33) . We prepared the following mutant oligonucleotide, 5'-CCCACAGCCCTCACCCAGCT-CACCAGGCCC-3'. After in vitro mutagenesis, the mutant protein C cDNA was sequenced by the dideoxy chain termination technique as described earlier, using double-stranded DNA as a template, to verify the mutation and the fidelity of the resulting sequence. The fragment containing the mutation was then inserted into pEUK-C or pLXSN, creating the mutated protein C expression vectors, pEUK-mPC or pLXSN-mPC.
Transient or stable expression ofrecombinant protein C. COS 7 and BHK cells were grown in Iscove's MEM containing 10% FCS and 500 ng/ml of vitamin K in 35-mm wells. COS 7 cells (3 X 105 per well) were transfected with either pEUK-PC or pEUK-mPC using the DEAE-dextran technique (34) . BHK cells were also transfected with both expression vectors by calcium phosphate coprecipitation method. The culture medium was removed from the cells for protein C measurement 48 h after transfection. After washing with PBS, the cells were lysed with 0.1% Nonidet P-40 (Sigma Chemical Co., St. Louis, MO) containing 10 mM PMSF, and the cell extracts were collected.
For the stable expression system, t-2 cells (3 x 105 per well), the ecotropic retrovirus packaging cell line (35) , were also transfected with each retroviral vector, pLXSN-PC or pLXSN-mPC, by calcium phosphate coprecipitation method, and some clones stably expressing normal or mutant protein C were selected in a medium containing the neomycin analog G418 (500 ,g/ml).
The levels of protein C in the culture media and in the cell extracts of COS 7, BHK and {-2 cells were measured by ELISA (Asserachrom Protein C®; Boehringer Mannheim). We also performed Western blot analysis of the cell extracts of 4-2 cells transfected with the retroviral vectors under reduced conditions. Northern blot analysis. To measure the transcript levels ofthe introduced transient expression vectors, cytoplasmic RNA samples (2, 4, or 20 Ag) from COS 7 cells transfected with pEUK-PC or pEUK-mPC were quantitated by absorbance at 260 nm, subjected to 1.2% formaldehyde-agarose gel electrophoresis, and transferred to a nylon membrane for RNA blot analysis. Membranes were then hybridized for 16 h to a protein C cDNA (1.8 kb) or a 778-bp PstI-XbaI fragment of human GAPDH cDNA as internal control (36) .
Immunoprecipitation of[ 5S] methionine-labeled recombinant protein C. i-2 cells (3 x 105 per well) transfected with each retroviral vector, pLXSN-PC or pLXSN-mPC, were prepared, washed with PBS, and incubated with 2 ml of methionine-free MEM containing 2% dialyzed FCS. After 1 h of incubation at 37°C, the cells were labeled with 40 ,Ci of [35S ]methionine in 2 ml ofthe methionine-free medium for 1 h, followed by chasing with an excess of unlabeled methionine (250 ,gg/ml) for 0 min, 15 min, 30 min, 1 h, 2 h, and 4 h. Cell extracts and media were harvested at appropriate intervals, after which recombinant protein C was immunoprecipitated from each sample with rabbit anti-protein C polyclonal antibody as described above. The immunoprecipitates were eluted from formaldehyde-fixed Staphylococcus aureus Cowan strain II (Pansorbin; Calbiochem-Behring, La Jolla, CA) (37) by boiling, electrophoresed on 12% SDS-PAGE, and autoradiographed.
Results
Protein C in the plasma ofthepatient and hisfamily. As shown in Fig. 1 (Fig. 3) . This result was confirmed by sequencing five more clones with different orientations. The deletion of this single guanine nucleotide apparently results in a frameshift mutation, which permits transcription past the normal termination codon through to the next chain termination signal. This is expected to cause the replacement of the last 39 amino acids at the carboxyl terminus with 81 abnormal amino acid residues (Fig. 4) phobic stretch of 17 amino acid residues was created in the carboxyl-terminal portion of Protein C-Nagoya (Fig. 4) .
Analysis offamily members. To determine the heredity of this mutation, we examined the genomic DNA ofthis patient's family members using the following mutagenic primers (28, 38, 39):
After amplifying the protein C genomic sequence by PCR using this mutagenic primer, digestion of the product of the normal allele with Aval yielded two sizes of fragments, 207 and 27 bp in length. This restriction site, however, was not present in the mutant allele, thus Aval digestion of the PCR product de- end of the protein C coding region are shown in the right and the left panels, respectively. The normal nucleotide and the deduced amino acid sequences with corresponding residue numbers are indicated at the right side. A guanine nucleotide has been deleted from the mutant allele in a stretch of four consecutive G residues, causing a frameshift The PCR products from 20 normal individuals produced two sizes of fragments (207 and 27 bp in length) when digested with AvaI, suggesting that they were homozygous for the normal allele (data not shown). AvaI digestion of the PCR product from the niece (II-2), who had normal levels of protein C antigen and activity, produced two bands (only the 207-bp fragment was detected) (Fig. 5) . On the other hand, the PCR products from the family members who were deficient for protein C (I-1, I-2, 1-3 and II-1 ) yielded three bands (234 bp, 207 bp, and the smaller 27-bp fragment) after Aval digestion (Fig.  5) , indicating that each of these family members carried one mutant and one normal allele. The 27-bp fragments were also undetected in these lanes.
A F T P K S A A T S T G S M G T S E T R K
Expression ofthe normal and mutant protein C genes. To verify whether the frameshift mutation identified in the patient could indeed result in protein C deficiency, expression vectors containing either the normal or the mutant protein C cDNA, were prepared and transfected into COS 7, BHK, and ,6-2 cells, as described in Methods. RNA blot analysis of cytoplasmic RNA isolated from COS 7 cells was performed using three different amounts of RNA, and the results did not reveal any significant difference in the transcript levels obtained from these two cDNAs (Fig. 6) . The levels of normal protein C in the culture media of COS 7 and BHK cells, as measured by ELISA, were 63.0±9.6 ng/ml and 20.8±3.3 ng/ml, respectively. On the other hand, the level of normal protein C in the cell extracts of COS 7 was 6.0±0.9 ng/ml, and BHK 1.9±0.3 ng/ml. Evidently, "90% of normal protein C synthesized in each cell line was secreted into the culture medium, whereas the amount of mutant protein C secreted was lower than the limit of detection by ELISA (<1 ng/ml). The cellular content ofmutant protein C, however, did not differ significantly (COS 7, 5.6±0.9 ng/ml; BHK, 1.9±0.3 ng/ml). Similar results were obtained in the stable expression experiments using ik-2 cells (data not shown). Protein C was not detected in the extracts of COS 7 and i/-2 cells transfected with the mutant protein C cDNA, under reduced conditions by Western blot analysis (data not shown). It is probable that the mutant protein C is very unstable within the cells; therefore, even with the stable expression system, it would be very difficult to detect the mutant protein C by Western blot analysis.
Pulse-chase analysis ofrecombinant protein C with [35S]-methionine labeling. To confirm further whether the deletion of 8857G really gave rise to the transport-deficient phenotype, recombinant protein C was immunoprecipitated from cell extracts or media of the transfected i1-2 cells, which had been pulse labeled for I h and then chased for varying periods up to 4 h with unlabeled methionine (Fig. 7) . Immediately after labeling, the cells transfected with pLXSN-PC contained a 62-kD form of protein C. During the 4-h chase period, essentially all of this 62-kD form was secreted into the media. The specificity of this analysis was verified by the absence of a corresponding protein when a normal rabbit IgG fraction was used as negative 62 control. In contrast, the recombinant Protein C-Nagoya appeared in the cells as an apparently larger species (66 kD) immediately after labeling. This difference in size between the normal protein C and Protein C-Nagoya is consistent with our prediction that an elongation ofthe amino acid sequence in the mutant protein C might be caused by the frameshift mutation. When chased with unlabeled methionine, Protein C-Nagoya remained within the cells for a prolonged period, as compared with the normal protein C. Apparently, only a small portion of the synthesized mutant molecule had been secreted into the medium even when the intracellular protein C had become almost undetectable. These observations indicate that most of the mutant protein C molecules must have undergone degradation within the cells while their transport was retarded in the intracellular transport pathway.
Discussion
The (43) . This theory predicts that frameshift mutations occur more frequently in runs ofidentical bases where displacement or "looping out" of bases from either the template strand (causing a deletion) or the growing strand (causing an insertion) can be stabilized by normal basepairing beyond the unpaired base during the replication process (44) . Human gene deletions are often associated with direct repeat sequences, an observation explained by the "slipped mispairing" hypothesis (45) . Consistently, in the protein C gene, a GGG direct repeat occurs flanking the site of deletion (Fig. 4) . A TGGGG sequence, found also in the tandemly repeated immunoglobulin switch (Sm) regions (46) , corresponds to the f3-globin deletion hotspot, codon 41 (45) , and is similar to both the known polymerase a arrest sites (47) and the human deletion hotspot consensus sequence (45) .
The single guanine nucleotide deletion we have found changes the chain termination signal and causes the replacement of the last 39 amino acids at the carboxyl terminus with 81 abnormal amino acid residues (Fig. 4) . To our knowledge, this type of frameshift mutation, which causes elongation of protein C, has not yet been previously reported. This elongated protein C (Protein C-Nagoya) should be -66 kD in size, but a protein C species with a molecular mass larger than normal was not detected in the patient's plasma by Western blot analysis (Fig. 2) , suggesting that there may be impaired secretion or rapid removal of the mutant protein C from circulation. Approximately 30 amino acid residues beginning with 176Gly are included in the highly conserved region common to members ofthe serine protease family (48) . 38"Gly is thought to be one of the residues (379Ser-38OTrp-381Gly) opposite the substrate binding pocket which interact with the side chains of the substrate in order to properly orient the bond that is to be cleaved (49) . Therefore, it is possible that the catalytic domain of protein C, which reacts with its substrates, is destroyed by this frameshift mutation. Although a comparison between the deduced amino acid sequences from the normal and the mutant DNA sequence of protein C shows an additional hydrophobic stretch of 17 amino acid residues at the carboxyl terminus of the mutant protein C (Fig. 4) , we cannot say at present whether this hydrophobic region is necessary for susceptibility to internal degradation.
Our expression study strongly suggests impairment of the mutant protein C secretion in this case. Recently, impaired intracellular transport has also been reported for several other naturally occurring or genetically engineered mutant proteins (50, 51 ) , and it has been hypothesized that a newly synthesized secretory or membrane protein would not be transported from the rough endoplasmic reticulum to the Golgi apparatus unless it folds into native or near-native conformation (52, 53) . The aberrant molecules may be removed from the rough endoplasmic reticulum or the Golgi apparatus before secretion through a mechanism that involves so-called "molecular chaperone"
proteins (54, 55) . In the case ofProtein C-Nagoya, a significant alteration in conformation of the native protein C molecule is easily predictable, as described above. This, in turn, probably causes improper folding, thereby affecting its posttranslational transport through the intracellular secretory compartments. The expression study also suggests that the mutant protein C is unstable within the cells, possibly attributed its altered conformation, because no abnormal intracellular accumulation was observed in spite of its apparently retarded secretion (Fig. 7) . Furthermore, this mutation does not appear to have any significant effect on transcription as shown in the Northern blot analysis of our transfection system (Fig. 6) . From these data, it seems likely that the production ofthe mutant protein C is not decreased within the cells, but rather the mutant protein C molecules are poorly secreted, and most of them are degraded in the producing cells. Moreover, Protein C-Nagoya secreted at a very low level might be removed from the circulation in vivo more rapidly than normal protein C molecule because of the possibly higher susceptibility of this abnormal molecule to the in vivo clearance mechanism. However, we have no experimen-2444 tal evidence for this at the present time. Further studies are required on the intracellular transport ofmutant secretory proteins, and we hope that Protein C-Nagoya will be a useful model for these studies.
